Outlook on Chronic Lymphocytic Leukemia: How Clinical Trials Can Improve Patient Outcomes

Deborah M. Stephens, DO


February 11, 2022

Deborah M. Stephens, DO, traces the course of therapeutic innovation for chronic lymphocytic leukemia from recent decades, in which established chemotherapeutic and immunologic approaches represented the standard of care, to later periods, in which various targeted therapies were developed and revolutionized patient outcomes, frequently within the context of clinical trials.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.